DOI:
10.1055/s-00000069
Seminars in Liver Disease
LinksClose Window
References
Neuschwander-Tetri BA, Loomba R, Sanyal AJ. , et al; NASH Clinical Research Network.
Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial.
Lancet 2015;
385 (9972): 956-965
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.